Post by Egle Therapeutics

We’re looking forward to #BIOEuropeSpring in Lisbon, Portugal, from March 23-25!​ ​ Our CEO, John Celebi, will be on the ground and sharing recent progress updates from our pipeline of Treg-modulating precision medicines, including lead program EGL-003 for atopic dermatitis, for autoimmune diseases and cancer.​ ​ Reach out if you’ll be attending and would like to learn more about Egle. To catch up on our most recent news, visit https://lnkd.in/eddY7usn ​